Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Morpheus-panBC in Metastatic Breast Cancer
NCT03424005Phase 2Recruiting
- Sponsor
- Roche
- Start
- Mar 2018
- Primary completion
- Sep 2030
- Modality
- Small Molecules, Monoclonal Antibodies
- Countries
- 9
01
Overview
A Phase 2 trial of atezolizumab, inavolisib in breast cancer, sponsored by Roche. Started Mar 2018; status: recruiting.
02
Drugs
atezolizumabinavolisib
03
Conditions
breast cancer
Beyond the preview
Go deeper on NCT03424005.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03424005.